by Emily Caldwell, The Ohio State University Credit: Unsplash/CC0 Public Domain The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each eye of a low dose of atropine, a drug used to...
